GenVault

Wuxi Advanced Therapies Inc. is a global leader in advanced therapeutics, providing a comprehensive platform of services to support the development and commercialization of innovative therapies. With a commitment to excellence, the company operates multiple offices worldwide, including key locations in China, Switzerland, and the United States. Dedicated to advancing healthcare solutions, Wuxi Advanced Therapies leverages cutting-edge technology and expertise to facilitate the research and production of biologics and cell therapies. Their extensive network and resources enable them to meet the diverse needs of clients across the pharmaceutical and biotechnology sectors. Generated from the website

Hava Health, Inc, based in Philadelphia, PA, is dedicated to revolutionizing the fight against nicotine addiction with their upcoming Hale Vaporizer system. Utilizing a patent-pending design, the device automatically reduces nicotine intake gradually over time, offering a clean and efficient solution for users. With a focus on simplicity and effectiveness, Hava Health ensures a seamless experience for users through a companion app, energy-efficient design, and connected technology that adjusts nicotine intake as needed. Committed to the highest manufacturing standards, the company aims to provide a cutting-edge solution to help individuals overcome nicotine addiction.Generated from the website

Neurokappa Therapeutics LLC is a Philadelphia-based company comprised of a team of scientists and business professionals dedicated to developing innovative medications for neurological diseases such as stroke, pain, and addiction. Leveraging their deep understanding of opioid receptors, they aim to create novel compounds that target these receptors, with potential therapeutic applications in stroke therapy, pain management, depression, and addiction therapy. The company's vision is to provide an effective alternative pathway for delivering medications for neurological diseases, particularly in out-of-hospital settings where intravenous access may not be readily available. With a focus on prioritizing the efficacy of action over the mechanism of actions, Neurokappa Therapeutics LLC is committed to continuously pursuing both scientific discoveries and the development of new indications for existing medications.Generated from the website